(Q79790097)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17306625%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17306625%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17306625%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Thomé-Souza MS

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17306625%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Kuczynski E

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17306625%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

15 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17306625%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17306625%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17306625%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17306625%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

417-425

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17306625%20AND%20SRC:MED&resulttype=core&format=json

The associations of psychopathology in epilepsy: a community study

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Relationship between interictal psychopathology and the type of epilepsy. Results of a survey in general practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Recurrence of Major Depressive Disorder in Hospitalized Children and Adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Interictal depression in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Depressive disorders in childhood. II. A longitudinal study of the risk for a subsequent major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Depression in epilepsy: etiology, phenomenology, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Depression in epilepsy. Significance and phenomenology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

The Use of Sertraline in Patients with Epilepsy: Is It Safe?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Major depression in community adolescents: age at onset, episode duration, and time to recurrence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Which factors may play a pivotal role on determining the type of psychiatric disorder in children and adolescents with epilepsy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Optimizing health outcomes in active epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Depressive Illness in Patients with Epilepsy: A Review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Psychopathology and its relationship to suicidal ideation in childhood and adolescence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Correlates of the medical lethality of suicide attempts in children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Suicidality in affectively disordered adolescent inpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Depression and epilepsy: how closely related are they?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

The natural history and treatment of child and adolescent affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Antidepressant drugs: indications and guidelines for use in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Audiogenic seizures data in mice supporting new theories of biogenic amines mechanisms in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Anticonvulsant and proconvulsant properties of viloxazine hydrochloride: pharmacological and pharmacokinetic studies in rodents and the epileptic baboon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Anticonvulsant effect of fluoxetine in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Citalopram as treatment of depression in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Symptoms of depression as possible markers of bipolar II disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Behavioral disorders in pediatric epilepsy: unmet psychiatric need

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Antidepressant and double antidepressant treatment for the affective disorder of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Depression in children and adolescents with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

A continuity between bipolar II depression and major depressive disorder?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Antidepressants and pediatric depression--the risk of doing nothing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Rate and predictors of prepubertal bipolarity during follow-up of 6- to 12-year-old depressed children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

The course of major depressive disorder in adolescents: I. Recovery and risk of manic switching in a follow-up of psychotic and nonpsychotic subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Clinical consequences of under-recognized bipolar spectrum disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Economic consequences of not recognizing bipolar disorder patients: a cross-sectional descriptive analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

How have the SSRI antidepressants affected suicide risk?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Efficacy and safety of antidepressants for children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

ACNP Task Force report on SSRIs and suicidal behavior in youth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

Suicidality in pediatric patients treated with antidepressant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

A black-box warning for antidepressants in children?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

The neurobiology of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Screening for bipolar disorder in the community

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.01.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEBEH.2007.01.004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17306625%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference